New Molecular Abnormalities Recognized in AML - 102243

Spotlight
Video

New Molecular Abnormalities Recognized in AML

Loading........
Description: Presented by Elli Papaemmanuil, PhD. In this video, Dr. Papaemmanuil explains the role of molecular abnormalities in AML oncogenesis, including mutations in DNA methyltransferase (DNMT), isocitrate dehydrogenase 1 and 2 (IDH1/2), and FMS-like tyrosine kinase 3 (FLT3). In addition, she will describe the rationale for targeting these molecular abnormalities to treat AML.
Shared By : MediComOncology
Posted on : 11/14/17
Added : 1 year ago